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Chronic obstructive pulmonary disease (COPD) is a common disease, associated with 
high morbidity and mortality, and is a leading cause of hospitalization and death in the 
elderly. Acute exacerbations contribute considerably to the diminished quality of life 
(QOL) in patients with COPD. Several etiologic factors alone or in combination cause 
acute exacerbation of COPD (AECOPD). Despite the rising mortality rate for COPD, 
public awareness of COPD is much lower than for other lung diseases.  
 
In Singapore, no documented data about rates of hospital readmissions for 
AECOPD is available and no previous studies have investigated the factors that influence 
the outcomes of care of COPD patients. The purpose of this study was to describe the 
outcomes of patients with COPD in terms of the rates of repeat hospitalization for 
AECOPD, and the QOL, and to evaluate factors associated with recurrent hospital 
readmissions for AECOPD and the QOL of COPD patients. These factors include socio-
demographic factors, clinical variables, psychologically-related factors and patient care 
factors.  
 
We conducted a cross-sectional study on 186 COPD patients who were 
hospitalized for AECOPD from April 2002 to March 2003 in the respiratory medicine 
departments of two large public sector general hospitals. Data on the outcome measures 
and associated factors of the patients in stable state were collected immediately prior to 
hospital discharge, and at one month after hospital discharge. At initial interview, we 
collected 186 COPD patients’ data on socio-demographic, clinical and patient care 
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characteristics on the day of their hospital discharge. And at re-interview, we completed 
questionnaires on the quality of life (SGQOL), level of family support and psychological 
distress for 146 patients at one month after their discharge. 
 
We found during the one year period prior to the current admission of the 186 
COPD patients, 85 patients (45.7%) reported two or more previous hospital readmissions. 
We also found a high prevalence of current or ex-heavy smokers, malnutrition, depression 
and consumption of psychotropic drugs and lack of care giver, pulmonary rehabilitation 
and vaccination. The multiple logistic regression analysis showed that the duration of 
COPD >5 years, lower FEV1% (<50%), consumption of psychotropic drugs and receipt of 
vaccination were significantly independently associated with frequent hospital 
readmissions. Frequent hospital readmissions (>=2) and depression were significantly 
independently associated with worse Symptom Scores of the SGQOL. Older age (>=75 
years), frequent hospital readmissions, lower FEV1%, severe dyspnea (degree of dyspnea 
>=3) and depression were significantly associated with worse Activity Scores. Lower 
FEV1%, severe dyspnea, anxiety, depression and poor housing type were independently 
associated with worse Impact Scores. Frequent hospital readmissions, lower FEV1%, 
severe dyspnea, anxiety and depression were significantly independently associated with 
worse Total Scores.  
 
In conclusion, this study has identified several factors that are associated with 
frequent readmissions and poor QOL and indicates that this disease remains poorly 
understood and an inadequately managed health problem, and that the QOL is worse in 
those with frequent admissions. These results of our study confirm that readmission for 
 vii


























LIST OF TABLES 
 
Table 1. Socio-demographic characteristics of COPD patients with frequent and 
 non-frequent re-admissions 
 
Table 2. Clinical characteristics of COPD patients with frequent and non-
frequent re-admissions 
 
Table 3. Patient care characteristics of COPD patients with frequent and non-
frequent re-admissions 
 
Table 4. Factors significantly associated with frequent re-admissions in COPD 
(Results of forward stepwise selection multiple logistic regression) 
 
Table 5. SGQOL Scores, Mean (SD) by socio-demographic characteristics of 
COPD patients 
 
Table 6.   SGQOL Scores, Mean (SD) by clinically-related characteristics of 
COPD patients 
 
Table 7. SGQOL Scores, Mean (SD) by psychologically-related characteristics 
of COPD patients 
 
Table 8.   SGQOL Scores,  Mean (SD), by patient care characteristics of COPD 
patients 
Table 9. Factors significantly associated with SGQOL scores from forward 
selection multiple regression analyses. 
 




AECB acute exacerbation of chronic bronchitis 
AECOPD  acute exacerbation of chronic obstructive pulmonary disease 
BMI body mass index 
BPQ Breathing Problems Questionnaire 
CMH chronic mucus hypersecretion 
COPD chronic obstructive pulmonary disease 
CRQ Chronic Respiratory Questionnaire 
FEV1 forced expiratory volume in 1 s 
FEV1% forced expiratory volume in 1 s percentage predicted 
HAD Hospital Anxiety and Depression Scale  
HRQL health-related quality of life 
ICU intensive care unit 
LTOT long-term oxygen therapy 
QOL quality of life 
SF-36 36-item short-form 
SGRQ St. George’s Hospital Respiratory Questionnaire 
SGQOL St. George’s quality of life  






PUBLICATIONS ARISING FROM WORK IN THIS THESIS 
 
Title: Factors Associated with Recurrent Hospitalizations and Quality of Life in Acute 
Exacerbation of COPD  
Abstract submitted and posted in 7TH NUS-NUH Annual Scientific Meeting. 2 & 3 




















Chronic obstructive pulmonary disease (COPD) is a common disease which is associated 
with high morbidity and mortality. It is a leading cause of hospitalization and death in the 
elderly. COPD serves as the fourth leading cause of death in North America, behind heart 
disease, cancer, and stroke, and is the only leading cause of death that is rising in 
prevalence [1] [2]. Despite the rising mortality rate for COPD, public awareness of COPD is 
much lower than for other lung diseases. 
 
DEFINITION OF COPD AND AECOPD 
 
According to the definition of the Global Initiative for Chronic Obstructive Lung Diseases 
[3], COPD is a disease state characterized by airflow limitation that is not fully reversible. 
The airflow limitation is usually both progressive and associated with an abnormal 
inflammatory response of the lungs to noxious particles or gases. The definition of acute 
exacerbation of COPD (AECOPD) reached by a working group of respiratory physicians 
from the United States and Europe was as follows: ‘a sustained worsening of the patient's 
condition, from the stable state and beyond normal day-to-day variations, that is acute in 






OUTCOMES OF COPD 
Mortality 
COPD is associated with substantial morbidity and mortality worldwide, and is expected 
to become the third leading cause of death and the fifth leading cause of disability by the 
year 2020 [5]. The WHO estimated 2.74 million deaths worldwide from COPD in 2000. In 
United States, mortality from COPD increased by 40% between 1979 and 1998. But 
prevalence, morbidity and mortality of COPD vary appreciably across countries and 
across different groups within countries. Even in developed countries, accurate 
epidemiological data on COPD are difficult and expensive to collect. Data from the third 
National Health and Nutrition Examination Survey (NHANES III) showed that 24 million 
adults in the United States had mild or moderate obstructive lung disease, compared with 
10 million adults reported a diagnosis of COPD responding to the National Health 
Interview Survey. It suggests that COPD is significantly under-diagnosed [6]. The 
imprecise and variable definitions of COPD have made it hard to quantify the morbidity 
and mortality of this disease in developed [7] and developing countries.  There is also a 
scarcity of data on COPD morbidity and mortality in Asian populations.  
 
Hospitalization for patients with acute exacerbations carries an associated in-
hospital mortality of 6 to 26% [8] [9] [10], and the long-term outcome is poor. In persons with 
FEV1 values < 0.75 L, the approximate mortality rate at 1 yr is 30% and at 10 yr 95% [11]. 
For those patients requiring prolonged mechanical ventilation in an intensive care unit 
(ICU) for an acute exacerbation, in-hospital mortality rates are substantially higher: 35% 
to 50% [12] [13] [14] [15], 1-year post-hospitalization mortality rates reach 40 to 65% [16] [17] [18] 
[19] [20] which is even higher for patients older than 65 years [19].  
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Hospitalization and Rehospitalization 
Hospitalization rates for COPD in many developed countries are rising dramatically. 
Investigators at the National Center for Health Statistics evaluated the trends in COPD-
related hospital discharges using data from the National Hospital Discharge Survey. In the 
United States, an estimated 553,000 hospital discharges were reported in 1995, a rate of 
21.2 per 10,000 population. Between 1992 and 1995, the overall discharge rate increased 
by 25.4% [21]. In Singapore, hospitalization rates from 1991 to 1998 have increased 
significantly among Malays and Indians [22]. COPD places a high economic burden on the 
healthcare system and society in all countries studied, with a particularly pronounced 
impact in the U.S.A and Spain [23]. In the United States, the burden of COPD is 
particularly high in secondary care, with over 660,000 hospital discharges for COPD 
recorded in 1998 [24]. The annual cost of hospital care for COPD in the U.S.A. was 
estimated at US$7.3 billion in 2000, 40% of the total direct (medical care) cost of the 
disease (US$18.0 billion) [25].  
 
Most hospitalizations for COPD are due to acute exacerbations. Hospitalization for 
acute exacerbation of COPD usually occurs in the advanced phase of disease. Half of 
those patients who are hospitalized are expected to be readmitted at least once in the 
ensuing 6 months [26] [27]. Sara L. Douglas et al [20] performed a prospective longitudinal 
study on 538 ICU patients who required >24 hrs of continuous in-hospital mechanical 
ventilation. It was indicated that over half of all patients alive at their index hospital 
discharge had at least one rehospitalization within the following 12 months. A majority 
(86%) of rehospitalizations occurred within the first 3 months after the index hospital 
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discharge. The 1-yr cumulative rehospitalization rate for long-term ventilator patients was 
52.6%, compared with 53.3% for short-term ventilator patients [20].   
 
 
Quality of Life 
After an acute exacerbation, most patients are expected to experience at least a temporary 
decrement in quality of life [28] [29] [30].  
 
A variety of studies exist as to methods of assessing quality of life in COPD. 
Cullen DL [31] identified 37 measures of COPD quality of life and functional status 
reported in selected literature in 1994-1997. Of these eight were measures of general 
health, 10 were COPD/disease-specific questionnaires, and 19 were functional status 
indices. Generic instruments provide a summary of health-related quality of life (HRQL), 
and specific instruments focus on problems associated with single disease states, patient 
groups, or areas of function. [32]  
 
Singh SJ [33] compared three disease-specific health-status measures to evaluate 
the outcome of pulmonary rehabilitation in COPD. The three disease-specific 
questionnaires are the Chronic Respiratory Questionnaire (CRQ), the St. George's 
Hospital Respiratory Questionnaire (SGRQ) and the Breathing Problems Questionnaire 
(BPQ). All three disease-specific measures were responsive to pulmonary rehabilitation. 
However the operator-led CRQ appears to be the most sensitive short-term outcome 
measure. In Hajiro T's [34] study the frequency distributions of the questionnaire scores 
showed that the SGRQ and the CRQ were normally distributed and that the BPQ was 
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skewed toward low scores. And the BPQ was found to be less discriminatory than the 
SGRQ and the CRQ in evaluating HRQL cross-sectionally. The SGRQ and CRQ have 
been showed precise, valid, and responsive and used extensively in the study of patients 
with COPD.  
 
Many generic measurements of HRQL, such as the 36-item short-form (SF-36), 
the 20-item Medical Outcomes Study short-form, sickness Impact Profile (SIP), have been 
used to measure HRQL. But their application to therapeutic trials in COPD may be 
limited by low sensitivity. The SIP appears to be relatively insensitive for mild to 
moderate airways disease and may not detect changes in health. In contrast, disease-
specific questionnaires may be more sensitive because a much higher proportion of their 
content is directly relevant to the disease under study. [35] Sometimes the SGRQ and SF-36 
were simultaneously used in COPD study [36].   
 
In many studies quality of life was measured by the SGRQ. A study was carried 
out in all acute medical wards of Aberdeen Royal Infirmary, Woodend and City Hospitals, 
Aberdeen over 12 months. [14] A total of 377 patients admitted with an exacerbation of 
COPD were identified in this time and 266 patients completed the SGRQ. Higher (worse) 
scores on the SGRQ were significantly related to readmission for COPD in the next 12 
months and Impact Scores were related to nebuliser provision independent of 
physiological measures of disease severity. Seemungal TA et al [15] found the SGRQ total 
and component scores were significantly worse in the frequent exacerbation group (E = 3 




The SGRQ, CRQ and BPQ questionnaires had weak correlations with some 
physiologic variables (VC, FEV1, and DL(CO)/VA) in Hajiro T’s study [34]. And 
pulmonary function and HRQL appear to highlight different aspects of disease severity in 
COPD. Therefore, both measures should be taken into account in order to get a complete 
picture of severity of disease.  
 
 
RISK FACTORS OF AECOPD 
 
Acute exacerbations contribute considerably to the morbidity and the diminished quality 
of life in patients with COPD. Several etiologic factors alone or in combination cause 
AECOPD. The major etiologic factor of AECOPD is infection of the respiratory tract [37], 
principally viral infections [38] [39]. These include vaccine-preventable infections like 
influenza and pneumococcus. Other factors including chronic mucus hypersecretion, 
malnutrition, home care, socio-economic factor and co-morbidity may also play a role in 
COPD exacerbation [40] [41] [42] [43]. 
 
Infection 
Numerous studies have been conducted to investigate airway infections as etiologic 
factors involved in COPD exacerbations. In a longitudinal study of a cohort of patients 
with moderate to severe COPD, lower respiratory tract infection was the most common 
identified cause of death [37]. Erhabor and Kolawole reviewed mortality due to COPD in 
Nigeria from 1990 to 1999 [44]. Out of 161 admissions, there were 41 deaths, accounting 
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for a mortality rate of 25.5%. Respiratory tract infection, lower socio-economic group and 
extremes of age were the most commonly identified risk factors for death.  In a recent 
study, it is found that the frequency of infective exacerbations was a major determinant of 
the quality of life of patients with bronchiectasis [45]. But no study has investigated 
associations between bacterial or viral infections and health-related quality of life in 
COPD patients. Furthermore, there are very few published studies that have investigated 
associations between infections and rehospitalizations. In a heavily influenza-vaccinated 
cohort study of older COPD adults (approximately 90% vaccinated each year), half of 
COPD subjects with moderate/severe COPD had at least one emergency-center visit 
and/or hospitalization for acute exacerbation and respiratory tract viral infections were 
documented in 23% of hospitalizations [46]. Although randomized trials of influenza 
vaccination in specific COPD populations have not been reported, the administration of 
the vaccine in elderly patients with COPD has been associated with a reduction in the risk 
of hospital admissions, outpatient visits, and mortality [47].   
 
The relationship between bacterial infection and COPD exacerbations is not 
precisely understood. Bacterial pathogens are present in around half of acute exacerbation 
patients [48] [49]. But it is difficult to determine the frequency in which bacterial infection is 
the major or sole cause of an exacerbation of COPD. Often, more than one possible 
explanation for an exacerbation is present, such as a viral upper respiratory tract infection 
or a co-morbid illness [50]. The difficulty of differentiating an active infection versus 
chronic colonization of the lower airways adds to this dilemma. Bronchoscopic studies, 
using sterile protected specimen brush, also have shown that approximately 25% of stable 
patients with COPD are colonized with potentially pathogenic bacteria [48] [51] [52]. Some 
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authors suggest that there is no compelling evidence that bacteria play a role in acute 
exacerbations [53]. Although bacterial colonization of the distal airways is common in 
stable COPD, patients with exacerbations often have higher numbers of organisms [54].  
Streptococcus pneumoniae, Haemophilus influenzae and pneumococci [55] [56] represent the 
majority of isolated bacteria. Thus, the background of colonization in the stable state has 
led to uncertainty concerning the role of bacteria during exacerbations. 
 
Studies have shown that respiratory viruses produce longer and more severe 
exacerbations and have a major impact on health-care utilization. [57] [58]. Two recent 
studies [57] [46] reported that at least one third of COPD exacerbations were associated with 
viral infections. Three rigorous studies [59] [60] [61] showed 18% to 34% of exacerbations 
attributed to viral (or mycoplasma) illness, and Influenza, parainfluenza, and coronavirus 
were the most frequent pathogens to be significantly associated with exacerbations. 
Estimates of the proportion of COPD exacerbations associated with viral infection range 
greatly from 7% [62] to 63% [63] due to significant differences in study design.  Several 
studies lacked adequate control by failing to record the frequency of viral infection during 
exacerbation-free periods. Others attempted to detect only selected pathogens. Variability 
in the definition of an exacerbation is another factor that may affect the percentage of 
exacerbations caused by viral illness. Finally, different serologic and isolation techniques 
account for some of the variety in study results. [54] 
 
Forced Expiratory Volume in 1 s (FEV1)  
The most commonly used way to express disease severity in COPD is by assessing the 
forced expiratory volume in 1 s (FEV1) as a measure of airway obstruction [64]. Both the 
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American Thoracic Society and the European Respiratory Society recommended a staging 
system for the assessment of COPD severity on the basis of actual FEV1 as a percentage 
of predicted (FEV1%pred) [65] [66].   
 
FEV1 is, besides age, considered to be the most important predictor of mortality in 
patients with COPD [67] [68]. However, a cross-sectional observational study on ambulatory 
COPD patients performed by Miravitlles M et al in 201 general practices located 
throughout Spain showed that FEV1 impairment explained only part of the risk of frequent 
exacerbations and hospital admissions [69]. Furthermore, it is difficult to compare or 
summarize results of different studies because there is considerable heterogeneity in 
outcome measures, instruments used, and study populations included.  
 
Low Body Mass Index (BMI) 
Weight loss is a frequently occurring complication in patients with COPD. Pouw EM et al 
[70] performed a retrospective case-control study on AECOPD hospital admissions in 1994 
and 1995 in a hospital in Netherlands. Cases were nonselectively readmitted within 14 
days after prior discharge and controls were not readmitted within 3 months. This study 
indicated weight loss during hospitalization and low BMI on admission were related to the 
increased risk of unplanned hospital readmission. Low BMI is an independent risk factor 
for mortality of COPD, and its association is strongest in subjects with severe COPD [40]. 
Landbo C et al [40] performed a prospective study in total 1,218 men and 914 women with 
COPD from the Copenhagen City Heart Study. They analyzed mortality from COPD and 
from all causes during 17 yr of follow-up. After adjustment for age, ventilatory function, 
and smoking habits, low BMI was predictive of a poor prognosis (i.e., higher mortality), 
 10
with relative risks (RRs) in underweight subjects as compared with that in subjects of 
normal weight of 1.64 in men and 1.42 in women. And the strongest association was 
found in severe COPD with RR for low versus high BMI 7.11. In a retrospective study 
with 400 COPD patients none of whom had received nutritional therapy, Schols AM et al 
[42] revealed that low BMI (p < 0.001), age (p < 0.0001) and low PaO2 (p < 0.05) were 
significant independent predictor of increased mortality. Moreover, a recent cross-
sectional study on 300 COPD outpatients in Europe showed that malnutrition was highly 
prevalent in home-assisted respiratory patients and was related to forced expiratory 
volume in one second [71]. In order to identify factors associated with the health-related 
quality of life (HRQL) perceived by patients with stable COPD, de La Fuente Cid R 
performed a prospective cohort study on 204 stable COPD patients in Spain and indicated 
that HRQL in stable COPD patients was partially related to nutritional status [72].  
 
Chronic Mucus Hypersecretion (CMH) 
A cross-sectional observational study on ambulatory COPD patients performed by 
Miravitlles M et al [69] in 201 general practices located throughout Spain showed chronic 
mucus hypersecretion (CMH) was significantly associated with the risk of frequent 
exacerbations while FEV1 impairment explained only part of the risk of frequent 
exacerbations and hospital admissions. COPD patients with CMH were more likely to die 
from pulmonary infection than COPD patients without CMH in a study on 14,223 
subjects followed for 10-12 years. [43] In contrast to these studies, a prospective cohort 
study over 15 years on subjects who had participated in the Copenhagen City Heart Study 
and were hospitalized with a discharge diagnosis of COPD found that the presence of 
CMH was not strongly associated with prognosis. However, mortality risk increased with 
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decreasing FEV1% predicted. [73]
 
Co-morbidity 
A cross-sectional study by Miravitlles M et al also indicated that severity of exacerbations 
provoking hospital admissions was associated with the presence of significant co-
morbidity. A prospectively study [42] on 2,414 ambulatory patients with AECB from 268 
general practices located throughout Spain suggested that baseline characteristics of the 
patients such as degree of dyspnea, coexisting ischaemic heart disease and number of 
previous visits to the general practitioner for respiratory problems are strongly associated 
with increased risk of relapse after ambulatory treatment of acute exacerbations of chronic 
bronchitis. In contrast, another prospective study on patients with moderate to severe 
COPD indicated that co-morbidities with COPD had not a significant impact on the risk 
of hospitalization for acute exacerbation [69]. Multivariate analysis showed that only 
PaCO2 and Ppa were independently related to the risk of hospitalization for acute 
exacerbation of COPD. 
 
Psychological Distress 
Many patients experience anxiety, depression, fatigue, coping difficulties, and somatic 
preoccupation [74], symptoms that may be related to the dyspnea associated with COPD. 
Inability to work and decreased capacity to participate in social and recreational activities 
are common and often lead to depression [75].  
 
Raffaele Antonelli Incalzi [103] analyzed the effects of COPD on health status, 
assessed by the Saint George's Respiratory Questionnaire (SGRQ) and five generic 
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outcomes: Barthel's index, 6-min walk test, mini mental state examination, geriatric 
depression scale, and quality-of-sleep index, in elderly patients in the Salute Respiratoria 
nell'Anziano Study from 1996 to 1997. The relatively low prevalence and the strong 
associated power of depression in this study testified that depression was an important 
marker of worse QOL in COPD patients. Although we know that the prevalence of 
depression in patients with advanced COPD is high [77], few studies have explored the 
relationship in COPD between depression and mortality. In a prospective study of 16 
patients with advanced COPD, Ashutosh et al [78] reported greater mortality at 4 years in 
depressed patients, even when differences in FEV1 were not present. Pedro Almagro’s 
prospective cohort study [79] of a larger series confirms that finding, he observed a strong 
relationship on 135 patients hospitalized for AECOPD between the presence of depression, 
assessed on the Yesavage scale, and medium-term mortality (death between 1 year and 3 
years after discharge).   
 
Management Factors and Home Care  
Comprehensive medical management starts with prevention which includes smoking 
cessation and immunization against influenza virus and pneumonia bacteria, but over time 
adds bronchodilators, anti-inflammatories, oxygen, adequate nutrition, exercise, control of 
anxiety and depression, and exacerbation management [80] [81]  Kessler R et al [82] assessed 
the frequencies of potentially modifiable risk factors of COPD exacerbation in patients 
hospitalized for this reason and found a moderate to high prevalence, suggesting 
unsatisfactory features in their management. This study recruited 353 patients with 
median forced expiratory volume in one second (FEV1) 31% of predicted and mean 
partial pressure of oxygen (PO2) 63+/-13 mmHg. Of these patients, 28% had not received 
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an influenza vaccination; a high number (86%) did not attend rehabilitation programmes; 
28% of patients with PO2 < or =55 mmHg were not using long-term oxygen therapy 
(LTOT); among LTOT users, 18% used it <15 h a day; 43% of the total failed in some of 
the essential inhaler manoeuvres; 26% were current smokers; 21% of noncurrent smokers 
were exposed to passive smoking at home. 
 
Several studies [83] [84] have found that patient compliance with COPD therapy is 
extremely poor. In the Lung Health Study, patient compliance with inhaled bronchodilator 
therapy by self-report at follow-up year 1 was just over 60%, declining to < 50% at year 5 
[84]. Generally, three types of noncompliance have been observed in COPD patients on 
chronic therapy: undercompliance, overcompliance, and improper use. Undercompliance 
is probably the most common compliance problem in COPD therapy, although improper 
use is also common. It is important to note that more than one type of noncompliance is 
possible in the same individual. Thus, studies that estimate noncompliance on the basis of 
one type of observed behavior probably underestimate the level of the problem [85]. At the 
same time, the family also plays an essential role in the life of the COPD patient with 
advancing disease. Family interaction requires that they have an understanding of the 
disease process and what to expect. But not all families are supportive; some family 
members may become disinterested or even hostile.  
 
Home care provided by respiratory therapists, such as oxygen, breathing 
equipment, supplies, and educating patients in use, cleaning, and maintenance of 
equipment, can significantly reduce the rehospitalization of COPD patients. A study on 
the effect of home respiratory therapy on hospital readmission rates in 418 patients with 
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COPD was performed by Roselle S and D'Amico FJ [28]. In the year prior to home 
respiratory therapy, the average number of hospital admissions per patient had been 1.28, 
with the average length of hospital stay being 18.25 days. During the home respiratory 
therapy study period of 12 months, the average number of hospital admissions was 0.48, 
with the average length of hospital stay being 6.09 days. 
 
The quality of post-hospitalization discharge care, in particular, pulmonary 
rehabilitation programmes of patient education and physiotherapy [70], is also an important 
determinant of outcomes. The goals of pulmonary rehabilitation are to enhance standard 
medical therapy and maximize functional capacity. Several studies have analyzed COPD 
patients' hospital and medical resource utilization before and after rehabilitation [86] [87]. In 
a randomized controlled study, Jensen [88] found that pulmonary rehabilitation led to 
significantly fewer hospitalizations over a 6 months follow-up of patients with COPD. 
Lertzman and Cherniack [87] reported an average decrease of 20 hospital days in the year 
after pulmonary rehabilitation, resulting in an estimated savings of $2,000 per patient. 
However, there have been no prospective randomized controlled studies that provide 
conclusive evidence regarding survival of COPD patients after pulmonary rehabilitation.   
 
Morbidity and mortality rates for COPD are inversely related to socioeconomic 
status and are higher in blue-collar than white-collar workers [92] [93]. In de La Fuente 
Cid’s prospective cohort study [72], health-related quality of life in 204 stable COPD 





In Singapore, no documented data about rates of hospital readmissions for AECOPD and 
case fatality are available. Such basic information is essential for evaluating the quality 
and outcomes of primary preventive and hospital care for COPD patients. Improving the 
quality of COPD management can greatly reduce unnecessary rehospitalization, mortality 
rate and social and economic burden. No previous studies in Singapore have investigated 
the factors that influence the outcomes of care of COPD patients. Thus, we conducted a 
cross-sectional study of hospitalized COPD patients. Data on 19 associated variables and 
2 outcome variables were systematically collected on discharge and at one month post 
discharge.  
 
The objectives of the present study were as follows: (1) To determine if frequent 
admissions for acute exacerbation of COPD were related to the level of patient care and 
management (2) To examine factors associated with recurrent hospital readmissions for 
AECOPD and the quality of life of COPD patients; these include socio-demographic 
variables (gender, age, ethnicity), socio-economic status, disease severity status (FEV1, 
SaO2, duration of COPD, degree of dyspnea, number of previous readmissions), other 
clinical factors (co-morbidity), disease precursor status (chronic mucus hypersecretion, 
nutritional status (BMI), smoking and alcohol consumption status);  psychological factors 
(depression and anxiety, use of psychotropic drugs), and the role of personal and social 
support, and care factors in predicting AECOPD (living arrangement), quality of care-
giver support, and patient’s level of treatment compliance, and clinical management 





An observational cross-sectional study was conducted on consecutive cases of COPD 
patients who were hospitalized for AECOPD from April 2002 to March 2003 in the 
Respiratory Medicine departments of the two largest general hospitals which admitted the 
great majority (80%) of COPD patients in Singapore. Data on the outcome measures and 
associated factors of the patients in stable state were collected immediately prior to 
hospital discharge, and at one month after hospital discharge.  
 
Study Population and Selection Criteria 
The study subjects were recruited from the Respiratory of Medicine Department of the 
Singapore General Hospital and Tan Tock Seng Hospital. The hospital database was used 
to select hospital admissions with chronic obstructive pulmonary disease as the main 
discharge diagnosis. During the study period, we recruited 186 COPD patients who met 
the eligibility criteria for inclusion in the study at initial interview on admission. 
Interviews and clinical assessments of the patients were made while they are in stable 
clinical states at two points in time, during their hospital stay prior to their discharge and 
at one month after their discharge (for 146 COPD patients).  
 
We used the Global Initiative for Chronic Obstructive Lung Diseases (GINA) 
criteria [3] to define COPD: FEV1/FVC < 70% and with or without chronic cough and 
sputum production. The study protocol was approved by the Ethics Committee of the 
hospitals. Inclusion criteria: (1) patients with a principle diagnosis of COPD defined 
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above (2) above 50 years old patients (3) current smokers or ex-smokers with a history of 
smoking equivalent to at least 20 pack-years (4) patients with a stable COPD status on 
discharge which was concluded from the records of the physician in charge. Both COPD 
patients with first-episode exacerbation and repeat admissions were included. Exclusion 
criteria: patients with active pulmonary tuberculosis, pulmonary fibrosis, pneumothorax, 
lung cancer, acute heart failure, acute myocardial infarction, stroke sequela, moderate to 
severe renal failure, moderate to severe Parkinson's disease, dementia, poor hearing, or 
who were mentally unable to answer a questionnaire or resident outside of Singapore were 
excluded from the study.  
 
We screened the hospital admission database from April 2002 to March 2003 in 
the Respiratory Medicine Department of Singapore General hospital and from Dec 2002 
to Mar 2003 in the Respiratory Medicine Department of Tan Tock Seng Hospital, and 
found 274 patients met these inclusion and exclusion criteria from all hospital admissions 
in the Respiratory Medicine departments of the two hospitals during the study period. 
Among the 274 patients, 71 patients refused to participate in this study as some of them 
were unwilling to do spirometry, some patients’ relatives did not agree with their 
participation, some were unwilling to be interviewed and others thought they were too old 
and ill to answer questions and perform spirometry. From the remaining 203 patients, 17 
were excluded because 2 of them with a thyroid cancer were unable to communicate, 1 
patient with Down's syndrome was unable to answer questions correctly and 14 patients 
were bed-bound or unable to walk. The participation rate was 186/274*100%=68%. The 
majority of the eligible patients who were not included in the study were similar to the 
186 patients, although a few of the 88 patients refused to perform spirometry because they 
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felt quite breathless. Thus, we possibly excluded a few most severely affected patients. In 
particular, we also excluded 7 patients with psychiatric problems were excluded according 
to our exclusion criteria.  
 
Outcomes and Associated Factors 
The outcome measures were the frequency of hospital admissions in the past one year and 
the quality of life as measured by the St. George Respiratory Questionnaire (SGRQ).  
Patients were categorized into two groups with ‘frequent readmissions’ (2 or more 
readmissions beside the current admission) and ‘non-frequent readmissions’ (None or less 
than 2 readmissions beside current admission).  
 
Measures at Initial Interview 
The following socio-demographic, clinical and patient care data were collected for every 
patient upon their discharge. Socio-demographic characteristics included gender, age, 
ethnicity, housing type and marital status. Clinical characteristics included smoking status, 
duration of COPD, co-morbid medical conditions, chronic mucus hypersecretion (CMH), 
FEV1%, oxygen saturation, BMI, degree of dyspnea, and consumption of psychotropic 
drugs in the past one year. Patient care characteristics included influenza or pneumococcal 
vaccination status and pulmonary rehabilitation program in the past one year and patient’s 
level of treatment compliance.  
 
The number of previous readmission in the past one year for COPD exacerbation 
was recorded as an outcome variable. The number of previous readmission in the past one 
year for COPD exacerbation beside the current admission was used to categorize two 
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groups of patients with frequent readmissions (>=2 readmissions in the past year) and 
non-frequent readmissions (no readmission or less than 2 readmissions). 
 
Smoking status (current or ex-smoker) was recorded. The duration of smoking 
(years) and the amount of tobacco consumption (sticks per day) were reported. Two 
categories of ex-smokers were defined: (1) Ex-heavy smoker (>=30 years and >= 20 
sticks/ d), (2) Ex-light smoker.  
     
Co-morbid diseases were codified according to the International Classification of 
Diseases, Ninth Revision. The following co-morbid medical conditions were recorded: (1) 
Asthma, (2) Coronary heart disease, (3) Chronic congestive heart failure, (4) Diabetes 
mellitus, (5) Renal failure, (6) Hypertension, (7) Psychiatric illness (8) Other diseases 
such as thyroid disease, gall-stone, renal calculus, benign prostate hyperplasia and cataract. 
All of these diagnoses were recorded from the patient problem list maintained in the 
medical charts.  
     
Dyspnea was defined as the perception of difficult breathing provoked by an 
activity not expected to produce it. The degree of dyspnea was assessed by a graded scale 
from 0 to 5: (0) Not breathless at all, (1) Breathlessness on heavy exercise, e.g., climbing 
2 or 3 floors, (2) Breathlessness on moderate exertion, e.g., climbing one floor or walking 
quickly, (3) Breathlessness on mild exertion, e.g., walking at normal speed, (4) 
Breathlessness on minimal exertion, e.g., slow walking, (5) Breathlessness on limited 
exertion, e.g., shower, bathing, washing. (New York Classification [91]) 
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The chronic mucus hypersecretion (CMH) was considered present when cough 
and sputum had lasted at least 3 months for more than 1 year. Questions from the British 
Medical Research Council respiratory questionnaire were used.  
     
The housing type was used as an indicator of socio-economic status and was 
categorized ordinally into 1=one-room apartment, 2=two-room apartment, 3=three-room 
apartment, 4=four-room apartment, 5=five-room apartment, 6=semi-detached house and 
terrace house. Two categories of socio-economic status were defined: (1) poor socio-
economic status (Public 1, 2 and 3 Room), (2) good socio-economic status (Public 4, 5 
room, Private apartment, semi-detached house and terrace house). 
     
Low body mass index (BMI) was used to represent poor nutritional status. The 
BMI was calculated as weight/height2 (kg/m2), and was categorized into two groups: 
underweight (less than 20 kg/m2) and normal weight (>=20 kg/m2). We measured the 
weight and height at initial interview and if these two data were missed at initial interview 
for some patients we would measure them at re-interview. We collected 168 BMI data at 
re-interview from these 186 patients.  
 
The oxygen saturation was measured non-invasively with a micro-oxymeter. We 
measured the resting pulse oximetry while the patients were breathing room air or oxygen 
because some patients were on long term oxygen therapy. We collected 183 SPO2 data 
from 186 patients. 
 
Pulmonary rehabilitation referred to a multidisciplinary rehabilitation program of 6 
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weeks occupational, physical, and nutritional therapy. The receipt of rehabilitation was 
recorded as whether the patient had completed this rehabilitation care program in the past 
one year. 
 
Patient’s level of treatment compliance was measured using a scale of three 
questions relating to the proportion of the times when the patient was able to take his 
medications as prescribed, go for follow-up and day-rehabilitation visits as required, 
undertake rehabilitative exercises as prescribed. 
 
Recording of pulmonary function values was made on an electronic 
microspirometer (Vitalograph TM). We recorded spirometric data both on the day of 
hospital discharge and at one month post discharge, since some patients were too 
breathless to perform spirometry satisfactorily on their discharge; at re-interview they 
appeared more stable. Spirometry was performed with the patient in the seated position. 
As a criterion for correct performance, two measurements had to be produced on each 
interview. The volume based on the effort (the best of four) having the greatest value of 
FEV1 and FVC was used in the analysis. Spirometric performance is based on American 
Thoracic Society (ATS) criteria for standardization and procedures [15]. We used a formula 
of microspirometry to develop FEV1% of Chinese, Malay and Indian males and females 
[92]. Acceptable spirometric data were obtained for 156 patients. 
 
Measures at Re-interview  
We recruited 186 consecutive COPD patients on the day of hospital discharge from April 
2002 to March 2003, and re-interviewed 146 patients from these 186 COPD patients from 
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May 2002 to March 2003. The re-interview was conducted about one month after their 
discharge at outpatient department in hospitals by trained nurse research assistants. 
 
At re-interview, height, weight, repeat spirometry, quality of life, psychological 
distress status and family support’s level were measured.  
     
Psychological distress: The Hospital Anxiety and Depression Scale (HAD) [90] was 
used to assess psychological distress. This brief self-report questionnaire had two 
subscales, one for anxiety and one for depression. Each subscale consisted of seven items 
that were scored 0-3. The maximum score for either depression or anxiety was 21 and the 
minimum score was 0. A score of 8 or more on either subscale is suggestive of 
psychological distress. The measure has good internal consistency and is a reliable and 
valid psychological measure for use in medically ill populations [93]. 
 
We used St. George’s Respiratory Questionnaire (SGRQ) [35] to measure the 
quality of life. It is a 76-item questionnaire with three components (Symptoms, which 
measured frequency and severity of respiratory symptoms; Activity, which focused on 
physical activities that either cause or were limited by dyspnea; and Impacts, which 
quantified the impact of the respiratory disease on the daily life by assessing 
psychological problems, need of care, adverse drug reactions, expectations for health, and 
disturbances of daily life); each item of the questionnaire had a weight that had been 
derived empirically. Because of weights of individual items, each section of the 
questionnaire was scored between 0 (no impairment) and 100 (maximal impairment); a 
cumulative score for the whole questionnaire was also computed and ranges between 0 
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and 100. The SGRQ was self-administered in booklet form. 
 
Family support’s level was measured by using a scale of six questions. The 
questionnaire was answered by the family member who took care of the patient. The six 
questions related to the degree of the care-giver’s understanding of her role and patient’s 
illness and treatment, the proportion of the times the care-giver supervised the patient 
taking medicine and exercising at home as prescribed by the doctor, took him/ her for 
follow up medical check ups and therapy as prescribed and encouraged him/ her to regain 
full recovery.  
 
Method of Data Collection 
Information of each subject was extracted from clinical case records in hospital and 
interviews with the patient and his care-giver by a trained nurse research assistant. 
Patients signed the consent form before we collected their data. The questionnaires were 
administered using Chinese and Malay translations where necessary for non-English 
speaking patients. Psychometric scales were self-administered where possible. The 
questionnaires were completed in a quiet room and the patient was sat at a desk. We 
explained to the patients why they were completing the questionnaires and how important 
it was for us to understand how they felt about their illness and the effect it had on their 
day-to day lives. To some patients who had difficulty in reading, the trained research 
assistant would read out the questions and their responses would be recorded. 
 
Statistical Analysis 
The outcome variables were hospital readmissions in the past one year and SGQOL. In 
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the primary analysis, the prevalence of socio-demographic, clinical and patient care 
characteristics were expressed as percentages of two patient groups with ‘frequent’ and 
‘non-frequent’ readmissions. Univariate analyses of factors that were associated with 
frequent readmissions were done using the chi-square statistic and estimates of the odds 
ratio with their 95% confidence intervals. Independent sample t test and one way ANOVA 
were used to compare means and SD of the SGQOL of groups defined by the levels of 
associated factors. For multiple comparisons, the statistical significance of pair-wise 
comparisons was evaluated after Bonferroni adjustment. A p-value < 0.05 was considered 
significant. 
 
Multivariate analyses were performed to analyze the independent risk factors for 
frequent readmissions for AECOPD, using logistic regression for dichotomous dependent 
variable, and multiple regression for the quality of life as continuous dependent variable. 
Both forward stepwise and full saturated methods were used for model development. All 
statistical analyses were performed using the Statistical Package for Social Sciences SPSS 






At initial interview, we collected 186 COPD patients’ data on socio-demographic, clinical 
and patient care characteristics on the day of their hospital discharge. And at re-interview, 
we completed questionnaires on the quality of life, level of family support and 
psychological distress for 146 patients on the next month after their discharge. Data for 18 
subjects on BMI from 186 subjects were not collected and data for 30 subjects on FEV1 
from 186 subjects were not measured. These two variables were measured either on initial 
interview or on re-interview, so some patients who did not attend the re-interview might 
have incomplete data.  
 
Frequent Readmissions for AECOPD 
During the one year period prior to the current admission of the 186 COPD patients, 125 
(67.2%) reported at least one previous hospital readmission for AECOPD, 85 patients 
(45.7%) reported two or more previous hospital readmissions. However, among the 85 
frequent readmission patients 16 patients experienced more than 10 readmissions and the 
highest number of readmissions was 20.  
 
The socio-demographic characteristics of COPD patients with ‘frequent 
readmissions’ (2 or more previous readmissions in past year) and ‘non-frequent 
readmissions’ (less than 2 previous readmissions) are summarized in Table 1. The 
majority of patients were males (83%). Eighty-one percent (151 of 186) were Chinese, 
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nine percent (16) were Malays and ten percent (19) were Indians. The 186 subjects aged 
50 to 95 years comprised 70 (38%) subjects aged above 75 years old; 126 (68%) subjects 
were married and lived with relatives, whilst 60 subjects who were divorced, widowed or 
still single; 86 subjects (46.2%) lived in small (1-3 room) public apartments.  
 
Males were 2 times more likely to develop frequent readmissions than females 
(OR= 2.35, 95% confidence interval (C.I.): 1.02 to 5.43). Malays were also more likely to 
have frequent readmissions (OR=2.09, 95% C.I.: 0.72-6.04), although statistically 
insignificant at p<0.05. Other socio-demographic variables (age, socio-economic and 
marital status) were not significantly associated with increased readmissions for AECOPD. 
 
Table 1. Socio-demographic characteristics of COPD patients with frequent and non-frequent 
re-admissions 





 N (%) 
Significance 
 test  
P value 
Odds Ratio  
(95% C.I.) 
Total 85   (100%) 101  (100%)   
Gender     
Male 76   (89.4%） 79   (78.2%) 0.049 2.35 (1.02 – 5.43)
Female 9    (10.6%) 22   (21.8%)   
Age     
>=75yr 28   (32.9%) 42   (41.6%) 0.288 0.69 (0.38 – 1.26)
<75yr 57   (67.1%) 59   (58.4%)   
Ethnicity     
Chinese 67   (78.8%) 84   (83.2%)   
Malay 10   (11.8%) 6     (5.9%) 0.194 2.09 (0.72 – 6.04)
Indians and Others 8    (9.4%) 11   (10.9%) 1.000 0.91 (0.35 – 2.40)
Housing type     
      Public 1,2,3 Rooms 41   (48.2%) 45   (44.6%) 0.659 1.16 (0.65 – 2.07)
      Public 4,5 room, 
executive, private 
44   (51.8%) 56   (55.4%)   
Marital status     
Single/divorce/widowed 23   (27.1%) 37   (36.6%) 0.208 0.64 (0.34 – 1.20)




The clinical characteristics of COPD patients with frequent and non-frequent 
readmissions are summarized in Table 2. All the subjects were current smokers or ex-
smokers with a history of smoking equivalent to at least 20 pack-years. Among them, 114 
(61%) subjects were current or ex-heavy smokers. 89 (53%) subjects were underweight 
(BMI<20 kg/m2), 138 (74%) subjects had at least one co-morbid disease and 73 (39%) 
subjects had two or more than two co-morbid diseases, and 62 (42%) subjects were 
depressed. The results of univariate analysis showed neither smoking, co-morbidities nor 
BMI was associated with increased hospital readmissions. On the other hand, patients 
with lower FEV1% (OR=1.87, 95% C.I.: 0.97-3.59), severe dyspnea (OR=1.80, 95% C.I.: 
0.98-3.28) and depression (OR=1.73, 95% C.I.: 0.89-3.37) were more likely to be 
frequently readmitted to hospital, although statistically insignificant at p<0.05. Patients 
with long duration of COPD (>5 years) were 2 times more likely to have frequent 
readmissions than those with short duration (OR= 2.51, 95% C.I.: 1.39 to 4.53). And 
patients with reported consumption of psychotropic drugs were 14 times more likely to 
develop frequent readmissions than those without consumption of psychotropic drugs 











Table 2. Clinical characteristics of COPD patients with frequent and non-frequent re-admissions 
 









Odds Ratio (95% 
C.I.) 
Total 85 (100%) 101  (100%)   
Smoking status     
Current or ex-heavy 
smoker * 
52 (61.2%) 62   (61.4%) 1.000 0.99  (0.55 – 1.79) 
Ex-light smoker 33 (38.8%) 39   (38.6%)   
BMI     
>=20 33 (38.8%) 46   (45.5%)  1.00 
<20 43 (50.6%) 46   (45.5%) 0.439 1.30  (0.71 – 2.40) 
Unknown 9   (10.6%) 9     (8.9%) 0.525 1.39  (0.50 – 3.89) 
Duration of COPD     
>5 yrs 52 (61.2%) 39   (38.6%) 0.003 2.51  (1.39 – 4.53) 
<=5 yrs 33 (38.8%) 62   (61.4%)   
No. Comorbidity     
>=2 37 (43.5%) 36   (35.6%) 0.465 1.32  (0.64 – 2.75) 
=1 27 (31.8%) 38   (37.6%) 0.849 0.91  (0.43 – 1.94) 
0 21 (24.7%) 27   (26.7%)  1.00 
Chronic mucus 
hypersecretion 
    
Yes 42 (49.4%) 38   (38%) 0.137 1.59 (0.89 –  2.87) 
No 43 (50.6%) 62   (62%)   
 85 100   
FEV1%     
>=50 23 (27.1%) 42   (41.6%)  1.00 
< 50 46 (54.1%) 45   (44.6%) 0.073 1.87  (0.97 – 3.59) 
Unknown 16 (18.8%) 14   (13.9%) 0.119 2.09  (0.87 – 5.03) 
Oxygen saturation ¶     
<=95 45 (53.6%) 52   (52.5%) 1.000 1.04  (0.58 – 1.87) 
>95 39 (46.4%) 47   (47.5%)   
Degree of Dyspnea     
>=3 58 (68.2%) 55   (54.5%) 0.070 1.80  (0.98 – 3.28) 
<3 27 (31.8%) 46   (45.5%)   
Anxiety ¶     
Yes (HAD>=8) 8  (12.5%) 7     (8.5%) 0.584 1.53  (0.52 – 4.47) 
No (HAD<8) 56 (87.5%) 75   (91.5%)   
Depressed ¶     
Yes (HAD>=8) 32 (50%) 30   (36.6%) 0.129 1.73  (0.89 – 3.37) 
No (HAD<8) 32 (50%) 52   (63.4%)   
Psychotropic drugs     
Yes 11 (12.9%) 1     (1%) 0.001 14.87(1.88 – 117.69)
No 74 (87.1%) 100   (99%)   
     
 
* (>=30yrs and >=20sticks/d);     ¶ Number do not total up because of missing data.  
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The patient care characteristics of COPD patients with frequent and non-frequent 
readmissions are summarized in Table 3. 163 (88%) subjects did not receive influenza or 
pneumococcal vaccination in the past one year. And only 25 (13%) subjects completed 
pulmonary rehabilitation. 85% subjects appeared fair to good patient compliance and 38% 
subjects had fair to good care giver, although 35% subjects showed the absence of a care 
giver. The results of univariate analysis showed neither poor patient compliance nor poor 
family support was significantly associated with increased hospital readmissions. On the 
other hand, patients who received either one vaccination were 3 times more likely to have 
frequent readmissions than those who received none of the two vaccinations (OR= 3.11, 
95% C.I.: 1.22 to 7.98). Respectively, patients who received influenza vaccination were 8 
times more likely to be frequently readmitted than those did not receive it (OR= 8.14, 
95% C.I.: 1.77 to 37.47), while patients who received pneumococcal vaccination seemed 
to be more likely to be frequently readmitted than those did not receive it (OR= 2.35, 95% 
C.I.: 0.83 to 6.66, although statistically insignificant at p<0.05). And patients who 
completed pulmonary rehabilitation were almost 3 times more likely to have frequent 


















Table 3. Patient care characteristics of COPD patients with frequent and non-frequent re-admissions 
 




 N (%) 
Significan
ce test  
P value 
 
Odds Ratio ( 95% 
C.I.) 
Vaccination     
    No ( none)  69 (81.2%) 94 (93.1%)   
Yes (influenza or 
        pneumococcal) 
16 (18.8%) 7  (6.9%) 0.024 3.11  (1.22 – 7.98) 
Influenza Vaccination     
    No 73 99   
    Yes 12 2 0.002 8.14  (1.77 – 37.47) 
Pneumococcal Vaccination     
    No 74 95   
    Yes 11 6 0.127 2.35  (0.83 – 6.66) 
Pulmonary rehabilitation     
    No 68 (80%) 93 (92.1%)   
    Yes 17 (20%) 8  (7.9%) 0.018 2.91  (1.19 – 7.12) 
Patient compliance     
    Poor          5-9 15 (17.6%) 12 (11.9%) 0.300 1.59  (0.70 – 3.61) 
    Fair to Good    3,4 70 (82.4%) 89 (88.1%)   
Family support     
Fair to good  (sum>=12) 32 (37.6%) 39 (38.6%)  1.00 
  Poor   (0<sum <12) 6  (7.1%) 4   (4.0%) 0.503 1.82  (0.48 – 7.04) 
No care giver     (sum=0) 26 (30.6%) 39 (38.6%) 0.605 0.81  (0.41 – 1.61) 
    Unknown 21 (24.7%) 19 (18.8%) 0.553 1.35  (0.62 – 2.93) 
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The results of logistic regression analysis of factors associated with frequent 
hospitalization for acute exacerbation are shown in Table 4. We included 19 associated 
variables as categorical or dichotomous variables in a forward stepwise multiple selection 
logistic regression analysis: gender, age, ethnicity, housing type, marital status, smoking 
status, BMI, duration of COPD, number of co-morbidity, CMH, FEV1%, degree of 
dyspnea, anxiety, depression, consumption of psychotropic drugs, receipt of vaccination 
and pulmonary rehabilitation program, patient compliance and family support. As can be 
seen, only 4 variables were significantly independently associated with frequent hospital 
readmissions: long duration of COPD (>5 years) (OR= 2.32; 95% CI: 1.09 to 4.92), lower 
FEV1% (OR=2.60; 95% CI: 1.18 to 5.74), consumption of psychotropic drugs (OR=13.47; 
95% CI: 1.48 to 122.92) and receipt of vaccination (OR=3.27; 95% CI: 1.12 to 9.57).  
 
Table 4. Factors significantly associated with frequent re-admissions in COPD (Results of forward 
stepwise selection multiple logistic regression) 
Significant Independent Factors Odds ratio 95% C.I. P value 
Duration of COPD > 5 years 2.32 1.09 – 4.92 0.029 
FEV1% < 50% 2.60 1.18 – 5.74 0.018 
Consumption of  psychotropic drugs  13.47 1.48 – 122.92 0.021 





Quality of Life (SGQOL) 
 
At re-interview, we ascertained the SGQOL Symptoms, Activity, Impact and Total Scores 
for 146 COPD patients. For all 146 subjects, the mean (SD) Symptom Scores was 53.2 
(20.8); the mean (SD) of Activity Scores was 63.9 (17.8); the mean (SD) of Impact Scores 
was 35.5 (19.7); the mean (SD) of Total Scores was 47.0 (15.9). The SGQOL scores by 
socio-demographic characteristics of COPD patients are shown in Table 5. The results of 
univariate analysis indicated that male gender was significantly associated with worse 
Symptoms Scores; older age (>=75 years) was significantly associated with worse 
Activity Scores; and poor housing type (public 1, 2, 3 rooms) was significantly associated 





















Table 5. SGQOL Scores, Mean (SD) by socio-demographic characteristics of COPD patients 







Total 146 53.2 (20.8) 63.9 (17.8) 35.5 (19.7) 47.0 (15.9) 
Gender      
Male 121 54.9 (21.4) 63.5 (18.6) 34.8 (19.9) 46.8 (16.4) 
Female 25 44.8 (14.8) 65.7 (13.3) 38.7 (18.4) 47.9 (13.45) 
P value  0.006 0.485 0.372 0.766 
Age      
>=75 yrs 54 50.0 (22.9) 68.6 (15.7) 36.5 (18.9) 48.5 (15.5) 
   <75 yrs 92 55.0 (19.3) 61.1 (18.4) 34.9 (20.1) 46.2 (16.1) 
   P value  0.164 0.013 0.631 0.399 
Ethnicity      
Chinese 118 53.1 (20.3) 64.7 (17.4) 36.3 (19.8) 47.7 (15.9) 
Malay 12 53.2 (23.7) 65.3 (21.3) 33.6 (18.7) 46.5 (14.9) 
Indians and Others 16 53.9 (23.1) 56.6 (16.8) 30.9 (19.4) 42.5 (16.4) 
P value  0.990 0.217 0.556 0.468 
Housing type      
   Public 1,2,3 Rooms 67 53.4 (22.0) 66.1 (18.2) 39.4 (20.9) 49.8 (16.7) 
   Public 4,5 room, 
executive, private 
78 53.0 (19.9) 61.7 (17.1) 31.4 (16.9) 44.2 (14.3) 
   P value  0.908 0.137 0.012 0.030 
Marital status      
Single/divorce/widowed 41 51.9 (21.0) 63.2 (13.3) 33.4 (14.2) 45.5 (12.4) 
    Married 105 53.6 (20.8) 64.1 (19.3) 36.3 (21.4) 47.6 (17.1) 
    P value  0.648 0.739 0.354 0.417 
 
 
The SGQOL scores, mean (SD) by clinically-related characteristics of COPD 
patients are shown in Table 6. A p value < 0.05 was considered significant. The results of 
univariate analysis indicated that frequent hospital readmissions (>=2) was significantly 
associated with worse Symptoms Scores; frequent readmissions, lower FEV1% (<50%) 
and severe dyspnea (degree of dyspnea >=3) was significantly associated with worse 
Activity Scores, worse Impact and Total Scores. The pairwise comparison analysis using 
Bonferroni adjustment showed two or more co-morbidity was significantly associated 




Table 6. SGQOL Scores, Mean (SD), by clinically-related characteristics of COPD patients 
 







Smoking status      
Current or ex-
heavy smoker  
91 52.6 (21.3) 63.4 (17.7) 36.5 (19.4) 47.3 (15.8) 
Ex-light smoker  55 54.1 (20.0) 64.7 (18.0) 33.9 (20.2) 46.6 (16.1) 
P value  0.682 0.680 0.440 0.781 
BMI      
<20  73 53.3 (20.4) 66.0 (17.7) 38.3 (19.4) 49.2 (15.3) 
>=20  72 52.4 (20.8) 61.2 (17.2) 32.3 (19.5) 44.4 (15.9) 
P value  0.803 0.106 0.066 0.069 
Frequent 
readmissions 
     
   Yes 64 58.0 (20.9) 70.4 (15.9) 40.6 (19.5) 52.5 (15.0) 
   No 82 49.4 (20.0) 58.7 (17.5) 31.5 (19.0) 42.7 (15.3) 
   P value  0.012 <0.001 0.005 <0.001 
Duration of COPD      
>5 yrs  72 55.1 (19.7) 66.7 (17.6) 38.0 (19.8) 49.5 (16.3) 
  <=5 yrs 74 51.3 (21.7) 61.2 (17.5) 33.0 (19.3) 44.6 (15.1) 
P value  0.274 0.062 0.121 0.059 
No. Co-morbidity      
    Two or more 59 47.4 (17.9)* 61.4 (14.8) 32.2 (17.8) 43.6 (13.8) 
  One 47 56.1 (21.7) 68.0 (17.0) 38.8 (20.1) 50.5 (16.2) 
  None 40 58.2 (22.1) 62.7 (21.8) 36.4 (21.4) 48.0 (17.6) 
    P value  0.19 0.146 0.209 0.071 
Chronic mucus  
hypersecretion 
     
 Yes 62 55.8 (20.2) 64.7 (15.2) 34.9 (17.8) 47.4 (18.0) 
    No 83 51.2 (21.2) 63.2 (19.6) 35.8 (21.1) 17.2 (18.9) 
    P value  0.187 0.634 0.785 0.789 
FEV1%      
< 50 84 54.6 (19.7) 68.0 (16.6) 41.2 (19.3) 51.5 (15.0) 
    >=50 60 50.4 (21.7) 58.0 (17.1) 27.4 (17.3) 40.5 (14.4) 
    P value  0.229 0.001 <0.001 <0.001 
Oxygen saturation      
<=95  71 51.4 (21.6) 64.8 (17.8) 35.7 (21.2) 47.1 (16.3) 
>95  75 54.8 (20.0) 63.0 (17.8) 35.3 (18.2) 46.9 (15.6) 
P value  0.331 0.545 0.894 0.935 
Degree of Dyspnea      
>=3   83 51.9 (21.0) 68.3 (16.9) 39.1 (20.5) 50.1 (15.9) 
  <3  63 54.9 (20.5) 58.0 (17.3) 30.7 (17.5) 43.0 (15.0) 
  P value  0.387 <0.001 0.009 0.007 
 




The SGQOL scores by psychologically-related characteristics of COPD patients 
are shown in Table 7. A p value < 0.05 was considered significant. The results of 
univariate analysis indicated that depression was significantly associated with worse 
Symptoms Scores; anxiety and depression was significantly associated with worse 
Activity Scores, worse Impact and Total Scores.  
 
Table 7. SGQOL Scores, Mean (SD) by psychologically-related characteristics of COPD patients 







Anxiety      
Yes (HA>=8) 15 51.5 (18.4) 74.6 (19.9) 52.6 (24.1) 59.1 (20.5) 
No (HA<8) 131 53.3 (21.1) 62.6 (17.2) 33.5 (18.2) 45.6 (14.7) 
P value  0.749 0.013 0.009 0.025 
Depressed      
Yes (HD>=8) 62 58.1 (21.2) 71.0 (15.9) 45.4 (20.0) 55.3 (15.3) 
No (HD<8) 84 49.5 (19.8) 58.6 (17.3) 28.2 (15.9) 40.9 (13.4) 
P value  0.013 <0.001 <0.001 <0.001 
Psychotropic drugs  use      
Yes 9 62.3 (22.4) 73.0 (13.6) 39.8 (23.0) 53.6 (16.7) 
    No 137 52.6 (20.6) 63.3 (17.9) 35.2 (19.5) 46.6 (15.8) 
  P value  0.174 0.113 0.500 0.202 
 
 
The SGQOL scores by patient care characteristics of COPD patients are shown in 
Table 8. A p value < 0.05 was considered significant. The results of univariate analysis 
indicated that pulmonary rehabilitation was significantly associated with worse Symptoms 
Scores; family support was significantly associated with worse Activity and Impact Scores. 
The pairwise comparison analysis using Bonferroni adjustment showed the absence of a 
care-giver was significantly associated with worse Activity and Impact Scores compared 







Table 8. SGQOL Scores, Mean (SD), by patient care characteristics of COPD patients 







Vaccination      
No 125 52.0 (20.6) 63.4 (17.2) 35.5 (19.8) 46.7 (15.8) 
    Yes 21 60.2 (21.2) 66.5 (21.0) 35.2 (19.0) 48.8 (16.5) 
    P value  0.094 0.468 0.937 0.578 
Pulmonary rehabilitation      
No 127 51.6 (20.1) 63.5 (17.8) 35.3 (20.0) 46.6 (16.0) 
    Yes 19 63.4 (22.9) 66.6 (17.7) 36.6 (17.4) 50.1 (15.2) 
    P value  0.021 0.475 0.791 0.360 
Patient compliance      
   Poor        5-9 16 59.2 (16.1) 63.4 (15.8) 40.2 (19.0) 50.4 (13.8) 
   Fair to Good  3,4 130 52.4 (21.2) 63.9 (18.0) 34.9 (19.7) 46.6 (16.1) 
   P value  0.220 0.920 0.314 0.371 
Family support      
No care giver (sum=0) 65 57.5 (20.6) 59.4 (17.2)* 30.4 (18.4)* 43.7 (14.9) 
Poor   (0<sum <12) 10 45.1 (21.8) 68.5 (19.7) 36.1 (26.8) 47.4 (22.7) 
Fair to good  
(sum>=12) 
71 50.3 (20.2) 67.3 (17.3) 40.1 (18.7) 50.0 (15.3) 
P value  0.056 0.024 0.015 0.066 
      
 
* ( p<0.05 vs ‘Fair and good family support’ ) from Bonferroni adjustment. 
 
 
The results of multiple regression analysis of factors associated with worse quality 
of life are shown in Table 9. From the previous univariate analysis results, we collected all 
associated variables of significance p<0.05 and of borderline significance p<0.10 for the 
three components and total one. We included 6 associated variables as categorical or 
dichotomous variables of worse Symptoms Scores in a forward stepwise selection 
multiple logistic regression analysis: gender, frequent readmissions, depression, 
pulmonary rehabilitation, vaccination and family support. Eight variables associated with 
worse Activity Scores were as follows: age, frequent readmissions, FEV1%, degree of 
dyspnea, anxiety, depression, family support and duration of COPD. Seven variables 
associated with worse Impact Scores were as follows: housing type, frequent readmissions, 
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FEV1%, anxiety, depression, family support and BMI. Ten variables associated with worse 
Total Scores were as followed: housing type, frequent readmissions, FEV1%, degree of 
dyspnea, anxiety, depression, BMI, duration of COPD, co-morbidity and family support. 
As can be seen, only 2 variables were significantly independently associated with worse 
Symptom Scores: frequent hospital readmissions (>=2) and depression; 5 variables were 
independently associated with worse Activity Scores: older age (>=75 years), frequent 
hospital readmissions, lower FEV1% (<50%), severe dyspnea (degree of dyspnea >=3) 
and depression; 5 variables were significantly independently associated with worse 
Impact Scores: lower FEV1%, severe dyspnea, anxiety, depression and poor housing type 
(public 1, 2, 3 rooms); and 5 variables were significantly independently associated with 
worse Total Scores: frequent hospital readmissions, lower FEV1%, severe dyspnea, 















Table 9. Factors significantly associated with SGQOL scores from forward stepwise selection 









 B Std. 
Error 
Beta   
Symptoms      
(Constant) 76.9 7.20  10.68 <0.001 
Number of Readmission -7.6 3.39 -0.18 -2.24 0.026 
Depression -7.6 3.40 -0.18 -2.22 0.028 
Activity      
(Constant) 133.6 8.12  16.45 <0.001 
Age -10.2 2.58 -0.28 -3.94 <0.001 
Number of Readmission -8.0 2.49 -0.23 -3.21 0.002 
FEV1% -9.2 2.54 -0.26 -3.62 <0.001 
Degree of Dyspnea -6.7 2.45 -0.19 -2.72 0.007 
Depression -11.5 2.41 -0.33 -4.78 <0.001 
Impact      
(Constant) 109.6 9.72  11.27 <0.001 
FEV1% -9.6 2.71 -0.25 -3.55 0.001 
Degree of Dyspnea -5.4 2.68 -0.14 -2.03 0.044 
Anxiety -11.4 4.41 -0.18 -2.58 0.011 
Depression -14.8 2.67 -0.38 -5.56 <0.001 
Housing type -5.3 2.64 -0.14 -1.99 0.048 
Total      
(Constant) 105.2 7.69  13.68 <0.001 
Number of Readmission -5.4 2.17 -0.17 -2.49 0.014 
FEV1% -7.1 2.19 -0.23 -3.26 0.001 
Degree of Dyspnea -4.3 2.15 -0.14 -2.02 0.046 
Anxiety -7.4 3.51 -0.15 -2.12 0.036 







The purpose of this study was to describe the outcomes of patients with COPD in terms of 
the rates of repeat hospitalization for AECOPD, and the quality of life, and to evaluate 
factors associated with recurrent hospital readmissions for AECOPD and the quality of 
life of COPD patients. These factors include socio-demographic and socio-economic 
status, clinical variables (disease severity status, other clinical diseases, disease precursor 
status), psychologically-related factors and patient care factors (quality of care-giver 
support, patient’s level of treatment compliance and clinical management: vaccination and 
rehabilitation). 
 
Prior studies have indicated that the mortality in COPD patients increases sharply 
beyond 65 years old [19] [94]. However, we could not find any previous study in the 
literature that demonstrated clear evidence of poor outcome in patients who were older 
than 65 years. In our study, older age (>=75years) was not associated with increased 
readmissions for AECOPD but was significantly independently associated with worse 
Activity Scores. This suggests that age, in and by itself, may not be an independent 
variable that may affect the readmission outcome. However as age increases, it does affect 
COPD patients’ physical activities. Among other socio-demographic factors, neither 
gender nor marital status was associated with the two outcomes of COPD in our study: 
frequent readmissions and the QOL. Housing type, which was used to assess the socio-
economic status, was found associated with Impact Scores of the SGQOL which 
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quantified the impact of the respiratory disease on daily life by assessing psychological 
problems, need of care, adverse drug reactions, expectations for health, and disturbances 
of daily life. One possible explanation is that the COPD patients with poor socio-
economic status had more worries than others about the fee-for- medical service 
(including consultation, treatment and ambulance fee), lack of family’s care and their or 
their care-givers’ work loss. The despair of disease recovery impacts their daily life 
additionally. 
 
The disease severity status was assessed by FEV1%, SaO2, duration of COPD, 
degree of dyspnea, and number of previous hospital readmissions. The lower FEV1% is 
shown to have impact on the disease outcome. In this study, lower FEV1% (<50%) was a 
significant independent factor associated with frequent hospital readmissions, while lower 
FEV1% as well as more severe dyspnea was associated with worse Activity, Impact and 
Total Scores of the SGQOL. The lower FEV1% has been found in some studies [47] [69] [95] 
[96] to be a predictor of hospital admissions for acute exacerbations, but not in others [30] [82] 
[97]. A possible reason for the discrepancy is that two of the latter studies [82] [97] included 
small numbers of patients who were selected on a narrow and low range of FEV1%. A 
positive relationship of FEV1% and risk of hospitalization for AECOPD is all the more 
coherent given that consistent findings have been observed of the strong impact of FEV1% 
in predicting mortality [73] [98] [99] and poor overall clinical outcomes that included death, 
readmission, intubation and intensification of drug therapy [41]. Degree of dyspnea was 
also observed in univariate analysis in this study to be strongly associated with frequent 
readmissions with borderline significance. Another study has also reported degree of 
dyspnea, in lieu of FEV1%, to be associated with increased risk of relapse of acute 
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exacerbations following ambulatory treatment for an index acute exacerbation [69].This 
suggests that lower FEV1% and severe dyspnea are important factors associated with poor 
outcomes in COPD patients. Long duration of COPD (> 5 years) was also associated with 
increased readmissions for AECOPD. Although in this study long duration of COPD was 
not a significant independent factor associated with poor quality of life, one recently 
published study [100] has shown that health status (synonymous with QOL) deteriorates 
steadily in patients with chronic COPD over a 3-year period. Frequent exacerbations 
indicated by hospital readmissions in this study is not only an outcome variable of COPD 
exacerbation, it also has an important impact on the health related quality of life. We 
found frequent readmissions (>=2) in the previous one year was a significant independent 
factor associated with poor quality of life particularly on Symptoms, Activity and Total 
domains. A previous prospective analysis [15] also showed that patients who had frequent 
exacerbations (>2/yr) over a 1-year period had significantly worse QOL scores after 1 
year than patients with less frequent exacerbations. We did not find a demonstrable 
relationship for oxygen saturation and readmission and poor QOL in this study. Although 
a lack of association with hospitalization has also been reported for gasometric indices 
[101], a preponderance of studies do demonstrate a positive association [47] [82] [96].  Our 
gasometric data had limitation as they were collected under different conditions (room air 
or with oxygen therapy), which could possibly explain the observed lack of association. 
 
The presence of co-morbidity has been previously identified as a risk factor 
increasing the risk of hospital admissions in ambulatory patients with mild to moderate 
COPD in the EOLO Study [69]. In our study, co-morbid diseases as a clinical factor 
included asthma, coronary heart disease, chronic congestive heart failure, diabetes 
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mellitus, renal failure, hypertension and psychiatric illness etc. Despite the high 
prevalence of 2 or more co-morbid diseases, we found that the presence of any one, two 
or more than two co-morbidities was not significantly associated with the readmission 
outcome. Our finding was in agreement with two other studies which also studied patients 
with moderate to severe COPD and indicated that co-morbidities with COPD had no 
significant association with increased risk of hospitalization for acute exacerbation [82] [96]. 
A possible reason is the selection criteria we applied in selecting patients into the study 
that excluded among others patients with acute heart failure and acute myocardial 
infarction. However, we did find that worse Symptoms Scores of the SGQOL were found 
in patients with two or more co-morbid diseases compared with those without co-morbid 
disease.  
 
We studied several predisposing factors such as chronic mucus hypersecretion 
(CMH, a disease precursor status), nutritional status (BMI) and smoking consumption 
status. The presence of the predisposing factors was quite prevalent: over half subjects 
were underweight, forty percent subjects presented CMH and sixty percent subjects were 
current or ex-heavy smokers. Multiple regression analysis showed none of the three 
factors was independently associated with frequent readmission and poor quality of life. A 
similar result was found in a 15 years’ prospective cohort study [73]. The presence of CMH 
and smoking were not strongly associated with prognosis on subjects who had 
participated in the Copenhagen City Heart Study and were hospitalized with a discharge 
diagnosis of COPD. One previous study of ambulatory COPD patients in primary care 
setting [69] has shown CMH to be associated with more frequent exacerbations of 
symptoms but not admission, suggesting that the effect of this precursor condition is more 
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likely to be evident in mild COPD. The majority of our patients were hospitalized patients 
with moderate to severe COPD. Two previous studies of small groups of highly selected 
patients demonstrated that low BMI [70] [82] were related to increased risk of readmission, 
but other studies that included BMI as a study variable in less selected groups of patients 
did not demonstrate this association [69] [96]. One possible explanation in our study for a 
lack of positive association with BMI is that anthropomorphic measures of nutritional 
status in non-Caucasian adults such as BMI < 20 kg/m2 may not be an adequate indicator 
of poor nutritional status in our population. Low BMI is commonly used to represent poor 
nutritional status. BMI is calculated as weight/height2 (kg/m2) and usually categorized into 
two groups: underweight (less than 20 kg/m2) and normal weight (>=20 kg/m2). We also 
analyzed the relation between BMI and outcomes of AECOPD using different categories, 
i.e. BMI < 18 kg/m2 and BMI < 15 kg/m2. However, our study continued to demonstrate a 
lack of a positive association even with using BMI < 15 kg/m2 as a category. This 
indicates that the BMI might not be an optimal indicator of poor nutritional status or 
predictor of AECOPD in our population.  
  
The development of psychological sequelae in conjunction with any physical 
illness is being increasingly recognized to have an impact on subsequent outcomes of care 
[78] [102]. The Hospital Anxiety and Depression Scale (HAD) questionnaire is a 
measurement tool specifically designed for hospital use, with good internal consistency 
and reliability [93], and has been proven useful as a valid psychological measure in 
medically ill patients, including the critical care population. Our study successfully 
showed depression was a significant independent factor associated with poor quality of 
life, associated with worse Symptoms, Activity, Impact and Total Scores. This result is 
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similar to that of a study carried out by Raffaele Antonelli Incalzi [103] which demonstrated 
that depression was an important marker of worse QOL in COPD patients. Hardly any 
previous studies have explored the role of psychological factors in determining the risk of 
increased acute exacerbations and hospital admissions. Only one previous study [96] has 
investigated psychotropic drugs consumption (as a ‘lifestyle’ variable, indicating 
psychological disturbance) with no positive association found. In our study, COPD 
patients with depression or anxiety appeared to be at greater risk of frequent hospital 
readmissions for acute exacerbations although the association was not statistically 
significant. However, we found the consumption of psychotropic drugs among those who 
had depression or anxiety was significantly associated with frequent hospital readmissions 
in this patient population. In our study, the psychotropic drugs include soporifics, 
tranquilizers, anxiolytics, and anti-depressants taken for emotional and mental problems, 
including insomnia. Psychotropic drug use may be considered a surrogate marker of more 
severe clinical depression, and lends support to the relationship between depression and 
frequent hospital readmission for AECOPD. However, since only 12 subjects had used 
psychotropic drug and they hardly remembered the exact drug names, it is possible that 
use of psychotropic drug, as an indicator of depression and predictor of outcome, may 
have been under-reported in this study. Thus, larger study sample size and prospective 
study design are needed to demonstrate the possible relation.   
 
Influenza and its complications are responsible for hundreds of thousands of 
excess hospitalizations, tens of thousands of excess deaths, and billions of dollars in 
health care costs [104] [105]. Influenza is generally seen as an important cause of acute 
COPD exacerbation, and patients with COPD are at especially high risk for the 
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consequences of influenza. The administration of the vaccine in elderly patients with 
chronic lung disease [104] has been overwhelmingly demonstrated to be associated with a 
reduction in the risk of hospital admissions, outpatient visits, and mortality, and the 
efficacy and cost effectiveness of influenza vaccination [105]. Despite recommendations for 
annual influenza vaccination, the prevalence of receipt of influenza vaccination was very 
low in our study population. Other recent studies have also documented inadequate 
vaccination rates in this risk group [106] [107]. At the same time, pneumococcal vaccination 
is strongly recommended for patients with COPD because it is safe and has been found to 
provide significant benefit for general patients in case-control and indirect cohort studies 
[108] [109] [110] as well as in a more recent randomized population-based trial. [111] Contrary 
to expectation, our study found that patients who received influenza vaccination were 
many times more likely to be frequently readmitted to hospital than those who were not 
vaccinated. This paradoxical result was also reported in two previous case-control and 
prospective studies [47] [96] of COPD patients admitted for acute exacerbation, in whom 
influenza vaccination was found to be associated with an increased risk of admission. This 
may be accounted for by the retrospective nature of the data that were collected in this 
study. It is also conceivable that COPD patients who experienced more frequent 
exacerbations as a result of viral infections were more willing to be vaccinated. 
Vaccination may also be more likely offered by physicians to those with more severe 
disease and frequent readmissions. Thus the degree of disease severity might be different 
between the groups with vaccination and without vaccination. Such a ‘confounding by 
indication’ occurs when the hospital readmission represents a perceived high risk or poor 
prognosis that results in an indication for treatment. [112] We consider that this was most 
likely to be the case in this study. Similar paradoxical associations shown in this study for 
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pneumococcal vaccination and pulmonary rehabilitation are also explainable in the same 
way. In addition, the unbalanced subject number of two groups (23 vs163) could confer 
with other particular characteristics that were not controlled in the multivariate models. 
Furthermore, the value of pneumococcal vaccination for elderly patients with COPD has 
also been controversial. A recent meta-analysis concluded that the pneumococcal vaccine 
provides partial protection against bacteremic pneumococcal pneumonia but not against 
other important outcomes, including bronchitis or mortality caused by pneumococcal 
infection. This protective benefit was seen only in low-risk groups and not among those 
patients with COPD [76]. It is worth adequately testing in further studies, as randomized 
controlled trials of influenza vaccination in specific COPD populations have not been 
reported. 
 
             Many controlled prospective studies indicated that pulmonary rehabilitation led to 
significantly fewer hospitalizations in patients with COPD [89] [90] [91]. However, the results 
of univariate analysis in our study showed COPD patients who completed pulmonary 
rehabilitation were almost 3 times more likely to have frequent readmissions than those 
without pulmonary rehabilitation. While we conducted this study, we found that the vast 
majority of the COPD patients were ignorant of pulmonary rehabilitation programme and 
were not prescribed pulmonary rehabilitation by their doctors. One possible explanation is 
that the doctors tend to prescribe pulmonary rehabilitation programme to the more severe 
patients compared with mild COPD patients. As a result, only 13% subjects completed 
pulmonary rehabilitation. Thus the degree of disease severity might be different between 
the groups with pulmonary rehabilitation and without pulmonary rehabilitation. And it is 
reasonable that the more severe patients would be more likely to develop frequent 
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readmissions than those mild patients without pulmonary rehabilitation. Another 
explanation is the retrospective nature of the data on pulmonary rehabilitation status and 
frequent hospital readmissions for AECOPD in the past one year. After some 
characteristics were controlled in the multivariate models, we found the completion of 
pulmonary rehabilitation was not related to frequent readmissions anymore. Small and 
unbalanced subject number of subjects is another possible explanation for the lack of 
positive association between the lack of pulmonary rehabilitation and poor outcomes. 
Further prospective trials with sufficient subjects are thereby needed. 
 
In our study, the majority (85%) of subjects showed fair to good treatment 
compliance and the patient compliance appeared not related to frequent readmissions and 
QOL. However, most studies elsewhere [83] [84] have found that patient compliance with 
COPD therapy is extremely poor. Even in the context of controlled trials, which involve 
more intensive intervention and monitoring than standard clinical settings, compliance has 
been low. In our study, the patient’s level of treatment compliance was measured using a 
simple scale of three questions relating to the proportion of the times when the patient was 
able to take his medications as prescribed, go for follow-up and day-rehabilitation visits as 
required and undertake rehabilitative exercises as prescribed. As these were self-reported 
measures, we probably underestimated the level of poor compliance. The improper use of 
drugs which we did not measure is probably another common compliance problem beside 
undercompliance in COPD therapy, as well as the fact that it is difficult to be identified 
and reported by patients. Additionally, more than one type of noncompliance is possible in 
the same individual. The underestimate of poor treatment compliance possibly explained 




We also found the lack of care giver support was not independently related to 
frequent readmissions and poor QOL. Previous studies have shown that home care 
provided by respiratory therapists, such as oxygen, breathing equipment, supplies, and 
educating patients in use, cleaning, and maintenance of equipment, can significantly 
reduce the rehospitalization of COPD patients [28]. However, we found that in Singapore, 
such home-based care provided by respiratory therapists is very infrequent, due to the 
excess medical demand, the shortage of home respiratory therapists and structural 
limitations of medical care system. We therefore assess the level of care givers support to 
represent the level of home care. This might explain different findings from various 
studies. Although intuitively family support and treatment compliance should have a 
favourable influence on COPD outcomes, whether caregiver’s support indeed make any 
empirical difference to prevent hospital readmissions and improve other outcomes is still a 
moot point. No previous studies have addressed the influence of family and psychosocial 
support in influencing COPD outcomes. Another possible explanation in our study for a 
lack of positive association with care giver is possibly the poor validity and reliability of 
the self-reported information provided by the care givers. Some care givers probably did 
not want to expose the lack of their understanding of their roles and patients’ illness and 
therefore exaggerated the degree of their understanding (71 of 146 subjects showed fair to 
good care giver) as we observed their knowledge about this disease was very limited.  
 
As in all other studies, our study results should be interpreted with due 
consideration of the limitations in the study design, the type of patients, selection criteria, 
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and the clinical measurements. In particular, it may be noted that hospitalization for acute 
exacerbation in our study subjects was defined as having had at least 2 previous 
readmissions beside the current admission, compared to those who had at least only one 
previous readmission (that is, two admissions or less in a year). Other studies have 
compared current one time admission for exacerbation versus admissions of patients with 
stable COPD [70] [96]. Such differences in case definition may account for varying 
sensitivities in detecting a given strength of associations. Our study population also tended 
to exclude the most severely affected patients who were unwilling or unable to participate. 
The cross-sectional study design with retrospective recall of data is another limitation of 
this study that can be addressed with prospective follow up of the patient cohort. These 
limitations, however, do not alter substantially the main findings of the present study.   
 
This study identifies several factors which are associated with frequent 
readmissions and poor QOL in COPD acute exacerbation. Since our study is a cross-
sectional study with retrospective recall of data, and the information of FEV1%, BMI, 
HAD, QOL and oxygen saturation was obtained simultaneously, we could merely 
conclude that these factors are associated factors. Some of the associations could be 
predictive factors, accompaniments or even a result of frequent admissions. It is 
conceivable that frequent hospital readmissions might result in a lower FEV1%, 
depression, the increased use of psychotropic drugs and lack of care-giver. Future research 
with prospective study design with sound design is needed to explore and validate the 
prediction model.  
 
Among the factors we studied, BMI, pulmonary rehabilitation, vaccination, 
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smoking status and the level of home care are remediable factors. Unfortunately, these 
factors did not appear to be significantly associated with the poor QOL and frequent 
readmissions for acute exacerbation of COPD in this study (for methodological reasons) 
although the high prevalence of these problems has revealed an inadequate management. 
The possible explanation is that we merely compared two groups of patients with or 
without these remediable factors retrospectively. Random controlled trials or prospective 
observational studies should be better designed to demonstrate more convincingly 
remediable factors are responsible for AECOPD, the importance to manage them and the 
effectivity of some treatment methods. We are continuing our study of this group of 
subjects with 6 month and 1 year follow up assessments. Additionally, more studies on 
other treatment methods could yield further insights into other important remediable 
factors for AECOPD. 
    
Conclusion 
In conclusion, this study identifies several factors that are useful and associated with 
frequent readmissions and poor QOL. We found that long duration of COPD, lower 
FEV1%, consumption of psychotropic drugs and receipt of vaccination were 
independently related to the risk of readmission to hospital for COPD exacerbation. 
Frequent readmissions, lower FEV1%, severe dyspnea and depression were significantly 
related to worse SGQOL scores. The high prevalence of lack of care-giver, pulmonary 
rehabilitation and vaccination and the presence of current or ex-heavy smokers, 
malnutrition, depression and consumption of psychotropic drugs indicate that this disease 
remains poorly understood and an inadequately managed health problem, although for 
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lack of statistical power, some of these factors were not demonstrated to be associated 
with the poor COPD outcomes in this study. These results of our study confirm that 
readmission for COPD exacerbation and poor quality of life in patients with COPD were 
associated with disease severity, psychosocial and health care factors.  
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Appendix  A: Schedule of Visits and Measurements for Patients  
 
 








Inclusion and exclusion criteria x   
Personal particulars  x  
Spirometry  x x 
Blood gas  x  
Disease severity status and co-morbidity  x  
BMI  x x 
Substance use  x  
Vaccination history  x  
Receipt of pulmonary rehabilitation care  x  
CMH  x  
Quality of home care   x 
Treatment compliance  x x 
SGRQ   x 
















Appendix B: Questionnaires 
Questionnaire 1.  St. George’s Respiratory Questionnaire (SGRQ) ---Part 1 
 
Part 1 Please tick ( 9) one box for each question: 
Questions about how much chest trouble 















1. Over the last year, I have coughed: □ 1 □ 2 □ 3 □ 4 □ 5 
2. Over the last year, I have brought up       
phlegm(sputum) □ 1 □ 2 □ 3 □ 4 □ 5 
3. Over the last year, I have had       
shortness of breath: □ 1 □ 2 □ 3 □ 4 □ 5 
4. Over the last year, I have had attacks      
of wheezing: □ 1 □ 2 □ 3 □ 4 □ 5 
5. During the last year, how many severe or very unpleasant attacks of chest trouble have you had?
Please tick ( 9) one: □1) More than 3 attacks □3) 2 attacks □5) No attacks 
 □2) 3 attacks □4) 1 attacks   
6. How long did the worst attacks of chest trouble last? (Go to question 7 if you had no severe 
attacks) 
Please tick ( 9) one: □1) A week or more □3) 1 or 2 days 
 □2) 3 or more days □4) Less than a day 
7. Over the last year, in an average week, how many good days (with little chest trouble) have you 
had? □1) No good days □3) 3 or 4 good days □5) Every  
Please tick ( 9) one: □2) 1 or 2 good days □4) almost everyday good  day is good 
8. If you have a wheeze, is it worsen in the morning?   
Please tick ( 9) one: □ 1. Yes □ 2. No 
   
Part 2---Section 1                                         Please tick ( 9) one:  
1. How would you describe your chest condition?  
□1. The most important problem I have  □3.Causes me a few problems 
□2. Causes me quite a lot of problems  □4.Causes no problem 
2. If you have ever had paid employment  
□1.My chest trouble made me stop work altogether □2. My chest trouble interferes with my  
□3.My chest trouble does not affect my work                         work or made me change my work 
 
Part 2---Section 2                          Please tick ( 9) in each box that applies to you these days: 
Questions about what activities usually make you feel breathless these days.: 
1. Sitting or lying still      □ 1. True       □ 2. False 
2. Getting washed or dressed       □ 1. True       □ 2. False 
3. Walking around the home      □ 1. True       □ 2. False 
4. Walking outside on the level    □ 1. True       □ 2. False 
5. Walking up a flight of stairs    □ 1. True       □ 2. False 
6. Walking up hills     □ 1. True       □ 2. False 




Questionnaire 1. St. George’s Respiratory Questionnaire (SGRQ) ---Part 2  
 
Part 2---Section 3                          Please tick ( 9) in each box that applies to you these days: 
Some more questions about your cough and breathlessness these days.  
1. My cough hurts   □ 1. True                  □ 2. False    
2. My cough makes me tired   □ 1. True                  □ 2. False    
3. I am breathless when I talk   □ 1. True                  □ 2. False    
4. I am breathless when I bend over   □ 1. True                  □ 2. False    
5. My cough or breathing disturbs my sleep   □ 1. True                  □ 2. False    
6. I get exhausted easily   □ 1. True                  □ 2. False    
  
Part 2---Section 4                            Please tick ( 9) in each box that applies to you these days: 
Questions about other effects that your chest trouble may have on you these days. 
1. My cough or breathing is embarrassing in public   □ 1. True     □ 2. False  
2. My chest trouble is a nuisance to my family, friends or neighbours   □ 1. True     □ 2. False  
3. I get afraid or panic when I cannot get my breath   □ 1. True     □ 2. False  
4. I feel that I am not in control of my chest problem   □ 1. True     □ 2. False  
5. I do not expect my chest to get any better   □ 1. True     □ 2. False  
6. I have become frail or an invalid because of my chest   □ 1. True     □ 2. False  
7. Exercise is not safe for me   □ 1. True     □ 2. False  
8. Everything seems too much of an effort   □ 1. True     □ 2. False  
     
Part 2---Section 5                             Please tick ( 9) in each box that applies to you these days: 
Questions about your medication, if you are receiving no medication go straight to section 6. 
1. My medication does not help me very much   □ 1. True     □ 2. False 
2. I get embarrassed using my medication in public   □ 1. True     □ 2. False  
3. I have unpleasant side effects from my medication   □ 1. True     □ 2. False  
4. My medication interferes with my life a lot   □ 1. True     □ 2. False  
  
Part 2---Section 6                Please tick ( 9) in each box that applies to you because of your 
breathing: 
These are questions about how your activities might be affected by your breathing.  
1. I take a long time to get washed or dressed   □ 1. True     □ 2. False  
2. I cannot take a bath or shower, or I take a long time   □ 1. True     □ 2. False  
3. I walk slower than other people, or I stop for rests   □ 1. True     □ 2. False  
4. Jobs such as housework take a long time, or I have to stop for rests   □ 1. True     □ 2. False  
5. If I walk up one flight of stairs, I have to go slowly or stop   □ 1. True     □ 2. False  
6. If I hurry or walk fast, I have to stop or slow down   □ 1. True     □ 2. False  
  □ 1. True     □ 2. False  7. My breathing mahes it difficult to do things such as walk up hills, 
carrying things up stairs, light gardening such as weeding, dance, 
play bowls or play golf 
  □ 1. True     □ 2. False  
  □ 1. True     □ 2. False  8. My breathing makes it difficult to do things such as carry heavy 
loads, dig the garden or shovel snow, jog or walk at 5 miles per hour, 
play tennis or swim 
  □ 1. True     □ 2. False  
9. My breathing makes it difficult to do things such as very heavy 
manual works, run, cycle, swim fast or play competitive sport 




Questionnaire 1. St. George’s Respiratory Questionnaire (SGRQ) ---Part 2 
 
Part 2---Section 7   Please tick ( 9) in each box that applies to you because of your chest trouble:
We would like to know your chest usually affects your daily life. 
1.  I cannot play sports or games   □ 1. True     □ 2. False    
2. I cannot go out for entertainment or recreation   □ 1. True     □ 2. False    
3. I cannot go out of the house to do the shopping   □ 1. True     □ 2. False    
4. I cannot do housework   □ 1. True     □ 2. False    
5. I cannot move far from my bed or chair   □ 1. True     □ 2. False    
  
Here is a list of other activities that your chest trouble may prevent you doing.  
(You do not have to tick these, they are just to remind you of ways in which your  
breathlessness may affect you): 
Going for walks or walking the dog 
Doing things at home or in the garden 
Sexual intercourse 
Going out to church, pub, club or place of entertainment 
Going out in bad weather or into smoky rooms 
Visiting family or friends or playing with children 
Please write in any other important activities that your chest trouble may stop you doing: 
 
Now would you tick in the box (one only) which you think best describe how your chest  
affects you 
□ 1. It does not stop me doing anything I would like to do   
□ 2. It stops me doing one or two things I would like to do 
□ 3. It stops me doing most of the things I would like to do 





















Questionnaire 2. Hospital Anxiety and Depression Scale (HAD) 
 
Doctors are aware that emotions play an important part in most illnesses. If your doctor knows 
about these feelings, he will be able to help you more. This questionnaire is designed to help your 
doctor to know how you feel. Read each item and place a firm tick in the box opposite the reply 
that comes closest to how you have been feeling in the past month. Do not take too long over your 
replies: your immediate reaction to each item will probably be more accurate than a long, thought-
out response. Tick only one choice in each section. 
 
A1. I feel tense or wound up □ 0. Not at all  □ 1. Time to time 
 □ 2. A lot of the time □ 3. Most of the time 
A2. I get a sort of frightened  □ 0. Not at all  □ 1. A little, but it does 
feeling as if something awful     not worry me 
is about to happen □ 2. Yes but not too badly □ 3. Very definitely  
    and quite badly 
A3. Worrying thoughts go  □ 0. Only occasionally □ 1. From time to time  
through my mind    but not too often 
 □ 2. A lot of the time □ 3. A great deal of the time 
A4.I can sit at ease and feel 
relaxed 
□ 0. Definitely □ 1. Usually 
 □ 2. Not often □ 3. Not at all 
A5.I get a sort of frightened 
feeling 
□ 0. Not at all  □ 1. Occasionally 
like butterflies in the stomach □ 2. Quite often □ 3. Very often 
A6. I feel restless, as if I have to  □ 0. Not at all □ 1. Not very much 
be on the move □ 2. Quite a lot □ 3. Very much indeed 
A7. I get sudden feelings of panic □ 0. Not at all □ 1. Not very often 
 □ 2. Quite often □ 3. Very often indeed 
     
D1. I still enjoy the things  □ 0. Definitely as much □ 1. Not quite so much 
I used to enjoy □ 2. Only a little □ 3. Hardly at all 
D2. I can laugh and see  □ 0. As much as I always could □ 1. Not quite as much now 
the funny side of things □ 2. Definitely not so much 
now 
□ 3. Not at all and quite 
badly 
D3. I feel cheerful □ 0. Most of the time □ 1. Sometimes 
 □ 2. Not often □ 3. Not at all 
D4. I feel as if I am  □ 0. Not at all □ 1. Sometimes 
slowed down □ 2. Very often □ 3. Nearly all the time 
D5. I have lost interest in  □ 0. I take just as much  □ 1. I may not take  
my appearance  care as ever  quite as much care 
 □ 2. I do not take as much  □ 3. Definitely 
  care as I should   
D6. I look forward with  □ 0. As much as ever I did □ 1. Rather less than I  
enjoyment to things □ 2.Definitely less than I used 
to 
□ 3. Hardly at all 
D7. I can enjoy a good  □ 0. Often  □ 1. Sometimes 
book or radio or TV program □ 2. Not often □ 3. Very seldom 




Questionnaire 3. Chronic Mucus Hypersecretion (CMH)  
 
These questions concern your condition in the one year period before your present admission. 
 
Chronic cough: In the past one year,     
Do you usually cough on getting up or first thing in the morning? □ 1. Yes    □ 2. No 
Do you usually cough during the day or night? □ 1. Yes    □ 2. No 
If yes to any of above,     
Do you cough like this on most days for as much as 3 months      
in the year? □ 1. Yes    □ 2. No 
For how many years have you had this cough?     ______ years     
     
Chronic phlegm: In the past one year,     
Do you usually bring up phlegm from your chest on getting up or      
first thing in the morning? □ 1. Yes    □ 2. No 
Do you usually bring up phlegm during the day or night? □ 1. Yes    □ 2. No 
If yes to any of above,     
Do you cough like this on most days for as much as 3 months      
 in the year? □ 1. Yes    □ 2. No 
For how many years have you had this phlegm?     ______ years     
     
Periods of cough and phlegm     
In the past 3 years have you had a period of increased cough and      
phlegm lasting for 3 weeks or more? □ 1. Yes    □ 2. No 
  
   
 
 




These are questions referring to the 12 months period 




















1. How much of the time did you regularly take      
medicines regularly as prescribed by the doctor? □ 1 □ 2 □ 3 □ 4 
2. How much of the time did you perform regularly  
the physical therapy and exercises as prescribed  
    
by the doctor                    □ 0. not applicable □ 1 □ 2 □ 3 □ 4 
3. How much of the time did you see the doctor      
regularly for outpatient follow up ?     □ 1 □ 2 □ 3 □ 4 





Questionnaire 5. Degree of Dyspnea 
 
 
Degree of  □ 0.  Not breathless at all 
dyspnea: □ 1.  Breathlessness on heavy exercise, e.g., climbing 2 or 3 floors 
 □ 2.  Breathlessness on moderate exertion, e.g., climbing one floor or  
       walking quickly 
 □ 3.  Breathlessness on mild exertion, e.g., walking at normal speed 
 □ 4.  Breathlessness on minimal exertion, e.g., slow walking 





Questionnaire 6. Family support --- Care-giver Efficacy 
 
1.  How much do you understand the nature of the illness and its treatment that the person you are 
taking care of has? 
□ 1. Not at all. □ 2. I understand some of it. 
□ 3. I understand most of it □ 4. I understand all of it. 
2. How much do you understand your role as a caregiver (how you are supposed to take care of 
him/her)? 
□ 1. Not at all. □ 2. I understand some of it. 
□ 3. I understand most of it □ 4. I understand all of it. 
3. How often do you supervise him/ her taking medicines as prescribed by the doctor? 
□ 1.  Not at all. □ 3. Most of the time 
□ 2.  Some of the time □ 4. All of the time 
4. How often do you supervise and assist him/her with the physiotherapy and exercises  at home as 
prescribed by the doctor / therapist. 
□ 1.  Not at all. □ 3. Most of the time 
□ 2.  Some of the time □ 4. All of the time 
5. How often do you take him/ her for follow up medical check ups and therapy as prescribed 
□ 3. Most of the time □ 1.  Not at all. 
□ 2.  Some of the time □ 4. All of the time 
6. How often do you encourage Him/Her to regain full recovery 
□ 1.  Not at all. □ 3. Most of the time 
□ 2.  Some of the time □ 4. All of the time 
    
 
 
 
